Skip to main content

JANE STREET GROUP, LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in TRVI

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$0
-$575,857 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
10 quarters on record

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Derivatives in TRVI

reported options exposure · as of Mar 31, 2026
CallValue
$2,499,335
CallShares
209,500
PutValue
$652,571
PutShares
54,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,247,243,084 across 314 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $652,571 54,700
2026-03-31 $2,499,335 209,500
2025-12-31 $575,857 45,995
2025-12-31 $540,864 43,200
2025-12-31 $865,132 69,100
2025-09-30 $166,530 18,200
2025-09-30 $1,853,790 202,600
2025-06-30 $491,753 89,900
2025-06-30 $260,372 47,600
2025-03-31 $726,495 115,500
2024-09-30 $109,981 32,929
2024-06-30 $197,775 66,368
2024-03-31 $58,974 17,094
2023-12-31 $88,377 65,953
2023-09-30 $53,628 24,600